Showing results (1341-1350 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|March 19, 2020
PROTAC Technology: Opportunities and ChallengesHongying Gao, Xiuyun Sun, Yu Rao
ACS Medicinal Chemistry Letters|March 19, 2020
Structure-Activity Relationship and Anticancer Profile of Second-Generation Anti-MRSA Synthetic RetinoidsAna V Cheng, Wooseong Kim, Iliana E Escobar, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic TherapyDaniel E Jeffries, Corina M Borza, Anna L Blobaum, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Epimers Switch Galectin-9 Domain Selectivity: 3N-Aryl Galactosides Bind the C-Terminal and Gulosides Bind the N-TerminalMukul Mahanti, Kumar Bhaskar Pal, Anders P Sundin, et al.
ACS Medicinal Chemistry Letters|January 16, 2020
Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible InhibitorsLukas Gorecki, Rudolf Andrys, Monika Schmidt, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-FluorinationHui Huang, Sanath K Meegalla, James C Lanter, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Acrylamide Functional Group Incorporation Improves Drug-like Properties: An Example with EGFR InhibitorsKuen-Da Wu, Grace Shiahuy Chen, Jia-Rong Liu, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of Novel Retigabine Derivatives as Potent KCNQ4 and KCNQ5 Channel Agonists with Improved SpecificityLei Wang, Guan-Hua Qiao, Hai-Ning Hu, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Synthesis, Biological Evaluation and Structure-Activity Relationships of Diflapolin Analogues as Dual sEH/FLAP InhibitorsLisa Vieider, Erik Romp, Veronika Temml, et al.
ACS Medicinal Chemistry Letters|January 19, 2019
Discovery of TD-0212, an Orally Active Dual Pharmacology AT1 Antagonist and Neprilysin Inhibitor (ARNI)R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, et al.
Pageof 438